New Alzheimer's Gene Discovered

One of only two genes with a known connection to the most common form of the disease, SORL1 may lead researchers to new treatment options

Researchers have discovered a second gene implicated in late-onset Alzheimer's disease, which sets in after age 65 and is the most common form of the disease. The discovery provides both a new drug development target and further evidence that scientists are on the right track in seeking medicines that will combat the disease. Currently, there are no drugs that will slow or reverse the brain cell death caused by Alzheimer's.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.